• reMYND announces positive Phase 2a clinical trial results for treatment of mild-to-moderate Alzheimer’s disease

    22 hours ago

  • Can we protect nerve cells from dying?

    22 hours ago

  • Resistance in Candida auris, how to tackle a deadly fungus

    Wednesday October 30th 2024

  • Rejuvenate Biomed, the NIHR Leicester BRC, and Wellcome Leap partner for Phase 2 Study in COPD-related sarcopenia

    Tuesday October 29th 2024

  • Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-Focused Pipeline

    Friday October 25th 2024

  • Repeated COVID vaccines enhance mucosal immunity against the virus

    Thursday October 24th 2024

  • 4Tissue Raises €2M to Advance Groundbreaking Breast Tissue Replacement Technology

    Wednesday October 23rd 2024

  • A new spatial biology standard for quantitative analysis of protein functions in tissue and cells

    Tuesday October 22nd 2024

  • Your news here?

  • Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

    Thursday October 17th 2024

  • InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research

    Wednesday October 16th 2024

  • A brown ale or hoppy lager? Even fruit flies have a preference.

    Tuesday October 15th 2024


Strategic Partners